CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 160 filers reported holding CRISPR THERAPEUTICS AG in Q4 2018. The put-call ratio across all filers is 1.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $364,878 | -33.1% | 6,756 | -15.6% | 0.10% | -30.1% |
Q1 2024 | $545,347 | +0.1% | 8,001 | -8.1% | 0.14% | -8.9% |
Q4 2023 | $544,994 | +40.3% | 8,706 | +1.8% | 0.16% | +27.6% |
Q3 2023 | $388,356 | -12.5% | 8,556 | +8.2% | 0.12% | -7.5% |
Q2 2023 | $443,842 | +24.9% | 7,906 | +0.6% | 0.13% | +18.8% |
Q1 2023 | $355,326 | +14.2% | 7,856 | +2.6% | 0.11% | +3.7% |
Q4 2022 | $311,216 | -40.6% | 7,656 | -4.5% | 0.11% | -41.9% |
Q3 2022 | $524,000 | -2.4% | 8,020 | -9.3% | 0.19% | +0.5% |
Q2 2022 | $537,000 | -13.5% | 8,840 | -10.6% | 0.18% | 0.0% |
Q1 2022 | $621,000 | -24.7% | 9,890 | -9.2% | 0.18% | -11.9% |
Q4 2021 | $825,000 | -34.0% | 10,890 | -2.5% | 0.21% | -30.7% |
Q3 2021 | $1,250,000 | -30.1% | 11,170 | +1.1% | 0.30% | -24.8% |
Q2 2021 | $1,788,000 | +44.3% | 11,045 | +8.6% | 0.40% | +18.5% |
Q1 2021 | $1,239,000 | -9.8% | 10,170 | +13.4% | 0.34% | -17.3% |
Q4 2020 | $1,373,000 | +73.8% | 8,970 | -5.0% | 0.41% | +37.9% |
Q3 2020 | $790,000 | +18.4% | 9,445 | +4.1% | 0.30% | +15.1% |
Q2 2020 | $667,000 | +73.7% | 9,075 | +0.3% | 0.26% | +41.5% |
Q1 2020 | $384,000 | -6.1% | 9,045 | +34.6% | 0.18% | +10.2% |
Q4 2019 | $409,000 | +752.1% | 6,720 | +397.8% | 0.17% | +690.5% |
Q1 2019 | $48,000 | +242.9% | 1,350 | +170.0% | 0.02% | +110.0% |
Q4 2018 | $14,000 | -36.4% | 500 | 0.0% | 0.01% | +25.0% |
Q3 2018 | $22,000 | -42.1% | 500 | -23.1% | 0.01% | -42.9% |
Q2 2018 | $38,000 | +442.9% | 650 | +52.9% | 0.01% | +366.7% |
Q2 2017 | $7,000 | -22.2% | 425 | 0.0% | 0.00% | -40.0% |
Q1 2017 | $9,000 | +28.6% | 425 | +30.8% | 0.01% | +25.0% |
Q4 2016 | $7,000 | – | 325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |